|
1
|
Rawicz-Pruszyński K, van Sandick JW,
Mielko J, Ciseł B and Polkowski WP: Current challenges in gastric
cancer surgery: European perspective. Surg Oncol. 27:650–656.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Miao L, Qi J, Zhao Q, Wu QN, Wei DL, Wei
XL, Liu J, Chen J, Zeng ZL, Ju HQ, et al: Targeting the STING
pathway in tumor-associated macrophages regulates innate immune
sensing of gastric cancer cells. Theranostics. 10:498–515.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Barok M, Le Joncour V, Martins A, Isola J,
Salmikangas M, Laakkonen P and Joensuu H: ARX788, a novel anti-HER2
antibody-drug conjugate, shows anti-tumor effects in preclinical
models of trastuzumab emtansine-resistant HER2-positive breast
cancer and gastric cancer. Cancer Lett. 473:156–163.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang Y, Lu JH, Wang F, Wang YN, He MM, Wu
QN, Lu YX, Yu HE, Chen ZH, Zhao Q, et al: Inhibition of fatty acid
catabolism augments the efficacy of oxaliplatin-based chemotherapy
in gastrointestinal cancers. Cancer Lett. 473:74–89.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Anczuków O, Akerman M, Cléry A, Wu J, Shen
C, Shirole NH, Raimer A, Sun S, Jensen MA, Hua Y, et al:
SRSF1-regulated alternative splicing in breast cancer. Mol Cell.
60:105–117. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Comiskey DF Jr, Montes M, Khurshid S,
Singh RK and Chandler DS: SRSF2 regulation of MDM2 reveals splicing
as a therapeutic vulnerability of the p53 pathway. Mol Cancer Res.
18:194–203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yoon JY, Wang JY and Roehrl MH: A combined
FAK, c-MET, and MST1R three-protein panel risk-stratifies
colorectal cancer patients. Transl Oncol. 13(100836)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Krishnaswamy S, Mohammed AK, Tripathi G,
Alokail MS and Al-Daghri NM: Splice variants of the extracellular
region of RON receptor tyrosine kinase in lung cancer cell lines
identified by PCR and sequencing. BMC Cancer.
17(738)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chakedis J, French R, Babicky M, Jaquish
D, Howard H, Mose E, Lam R, Holman P, Miyamoto J, Walterscheid Z,
et al: A novel protein isoform of the RON tyrosine kinase receptor
transforms human pancreatic duct epithelial cells. Oncogene.
35:3249–3259. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Milan M, Benvenuti S, Balderacchi AM,
Virzì AR, Gentile A, Senetta R, Cassoni P, Comoglio PM and Stella
GM: RON tyrosine kinase mutations in brain metastases from lung
cancer. ERJ Open Res. 4(4)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao S, Cao L and Freeman JW: Knockdown of
RON receptor kinase delays but does not prevent tumor progression
while enhancing HGF/MET signaling in pancreatic cancer cell lines.
Oncogenesis. 2(e76)2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Paronetto MP, Passacantilli I and Sette C:
Alternative splicing and cell survival: From tissue homeostasis to
disease. Cell Death Differ. 23:1919–1929. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhou DH, Li C and Yang LN: Variant RONΔ160
of the RON receptor tyrosine kinase promotes the growth and
invasion in vitro and in vivo in gastric cancer cell lines. Cancer
Cell Int. 15(9)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yoon M and Rikkerink EHA: Rpa1 mediates an
immune response to avrRpm1Psa and confers resistance against
Pseudomonas syringae pv actinidiae. Plant J. 102:688–702.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang D, Liu K, Hu W, Lu X, Li L, Zhang Q,
Huang H and Wang H: Prenatal dexamethasone exposure caused fetal
rats liver dysplasia by inhibiting autophagy-mediated cell
proliferation. Toxicology. 449(152664)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
van Bergeijk P, Seneviratne U,
Aparicio-Prat E, Stanton R and Hasson SA: SRSF1 and PTBP1 are
trans-acting factors that suppress the formation of a CD33 splicing
isoform linked to Alzheimer's disease Risk. Mol Cell Biol.
39(39)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Coomer AO, Black F, Greystoke A, Munkley J
and Elliott DJ: Alternative splicing in lung cancer. Biochim
Biophys Acta Gene Regul Mech. 1862(194388)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Barbagallo D, Caponnetto A, Brex D,
Mirabella F, Barbagallo C, Lauretta G, Morrone A, Certo F, Broggi
G, Caltabiano R, et al: CircSMARCA5 regulates VEGFA mRNA splicing
and angiogenesis in glioblastoma multiforme through the binding of
SRSF1. Cancers (Basel). 11(11)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhou X, Wang R, Li X, Yu L, Hua D, Sun C,
Shi C, Luo W, Rao C, Jiang Z, et al: Splicing factor SRSF1 promotes
gliomagenesis via oncogenic splice-switching of MYO1B. J Clin
Invest. 129:676–693. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bonomi S, di Matteo A, Buratti E, Cabianca
DS, Baralle FE, Ghigna C and Biamonti G: HnRNP A1 controls a
splicing regulatory circuit promoting mesenchymal-to-epithelial
transition. Nucleic Acids Res. 41:8665–8679. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ghigna C, Giordano S, Shen H, Benvenuto F,
Castiglioni F, Comoglio PM, Green MR, Riva S and Biamonti G: Cell
motility is controlled by SF2/ASF through alternative splicing of
the Ron protooncogene. Mol Cell. 20:881–890. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lu H, Han N, Xu W, Zhu Y, Liu L, Liu S and
Yang W: Screening and bioinformatics analysis of mRNA, long
non-coding RNA and circular RNA expression profiles in
mucoepidermoid carcinoma of salivary gland. Biochem Biophys Res
Commun. 508:66–71. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang J, Sun G, Hu Y, Yang J, Shi Y, Liu H,
Li C, Wang Y, Lv Z, Niu J, et al: Extracellular vesicle lncRNA
metastasis-associated lung adenocarcinoma transcript 1 released
from glioma stem cells modulates the inflammatory response of
microglia after lipopolysaccharide stimulation through regulating
miR-129-5p/high mobility group box-1 protein axis. Front Immunol.
10(3161)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kun-Peng Z, Chun-Lin Z and Xiao-Long M:
Antisense lncRNA FOXF1-AS1 promotes migration and invasion of
osteosarcoma cells through the FOXF1/MMP-2/-9 pathway. Int J Biol
Sci. 13:1180–1191. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhao SJ, Kong FQ, Jie J, Li Q, Liu H, Xu
AD, Yang YQ, Jiang B, Wang DD, Zhou ZQ, et al: Macrophage MSR1
promotes BMSC osteogenic differentiation and M2-like polarization
by activating PI3K/AKT/GSK3β/β-catenin pathway. Theranostics.
10:17–35. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu CY, Zheng C, Xia EJ, Quan RD, Hu J,
Zhang XH and Hao RT: Lysophosphatidic acid receptor 5 (LPAR5) plays
a significance role in papillary thyroid cancer via
phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin
(mTOR) pathway. Med Sci Monit. 26(e919820)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jiang L, Liu XQ, Ma Q, Yang Q, Gao L, Li
HD, Wang JN, Wei B, Wen J, Li J, et al: hsa-miR-500a-3P alleviates
kidney injury by targeting MLKL-mediated necroptosis in renal
epithelial cells. FASEB J. 33:3523–3535. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xu R, Wu J, Zhang X, Zou X, Li C, Wang H,
Yuan M, Chen M, Sun Q and Liu S: Modified Bu-zhong-yi-qi decoction
synergies with 5 fluorouracile to inhibits gastric cancer progress
via PD-1/PD-L1-dependent T cell immunization. Pharmacol Res.
152(104623)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ling Y, Kuang Y, Chen LL, Lao WF, Zhu YR,
Wang LQ and Wang D: A novel RON splice variant lacking exon 2
activates the PI3K/AKT pathway via PTEN phosphorylation in
colorectal carcinoma cells. Oncotarget. 8:39101–39116.
2017.PubMed/NCBI View Article : Google Scholar
|
